Brief: BML Investment Partners Reports 14.2% Passive Stake In AN2 Therapeutics
12/08/2024 21:55
Aug 12 (Reuters) - AN2 Therapeutics Inc ANTX.O :
* BML INVESTMENT PARTNERS, L.P. REPORTS 14.2% PASSIVE STAKE
IN
AN2 THERAPEUTICS AS OF AUGUST 9, 2024- SEC FILING
Source text for Eikon: ID:n0001373604-24-000062
Further company coverage: ANTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AN2 Therapeutics
See all newsBrief: AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(C)(4)
Brief: An2 Therapeutics Announces Extension Of Funding For Tuberculosis Research Collaboration With Gsk
AN2 Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
AN2 Therapeutics Q2 net loss widens on higher R&D costs
AN2 Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview